搜索临床试验以:Inotuzumab 奥佐米星 (IO)
总计413个结果
-
Gruppo Italiano Malattie EMatologiche dell'Adulto招聘中
-
Pfizer完全的白血病 | 前体 b 细胞淋巴细胞白血病-淋巴瘤 | 急性淋巴细胞白血病美国, 西班牙, 台湾, 新加坡, 印度, 匈牙利, 火鸡, 波兰
-
WellSpan HealthUniversity of Pennsylvania完全的
-
Second Affiliated Hospital, School of Medicine,...The First Affiliated Hospital with Nanjing Medical University; Shanghai Zhongshan Hospital; West... 和其他合作者招聘中
-
Wyeth is now a wholly owned subsidiary of Pfizer完全的
-
Implandata Ophthalmic Products GmbH完全的
-
Implandata Ophthalmic Products GmbH完全的
-
Eye & ENT Hospital of Fudan UniversityShandong Provincial Hospital; Children's Hospital of Fudan University; Xinhua Hospital, Shanghai... 和其他合作者招聘中
-
Immune-Onc TherapeuticsRegeneron Pharmaceuticals主动,不招人
-
Immune-Onc TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)招聘中
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical Center; Ewha Womans University...未知
-
Implandata Ophthalmic Products GmbH完全的
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdPeking University完全的
-
Haukeland University HospitalMinistry of Defence, Norway完全的
-
UNICANCER招聘中黑色素瘤 | 肾细胞癌 | 头颈癌 | 肝细胞癌 | 肺癌转移 | 膀胱癌 | 三阴性乳腺癌 | 默克尔细胞癌法国
-
PfizerUCB Pharma完全的淋巴瘤美国, 比利时, 日本, 大韩民国, 德国, 香港, 匈牙利, 荷兰, 新加坡
-
National Taiwan University HospitalMinistry of Science and Technology, Taiwan; Teleflex完全的
-
Pfizer完全的
-
Novartis Pharmaceuticals撤销
-
Institute of Hematology & Blood Diseases Hospital尚未招聘
-
Nantes University HospitalChugai Pharmaceutical; French Innovative Leukemia Organisation完全的
-
Versailles Hospital主动,不招人急性淋巴细胞白血病 (ALL) - 费城染色体 (Ph)-阴性 CD22+ B 细胞前体 (BCP)法国
-
Institute of Hematology & Blood Diseases Hospital尚未招聘